Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/27/25 16:23 | 10/24/25 | CRBP | Health | Drug | Pharmaceutical Preparations | Cohen Yuval | MA | DO | CEO | 2 | M.dm | 589 | 10.66 | 0 | 55 | 67 | 138 | D | ||||||||||||||
10/27/25 16:23 | 10/24/25 | CRBP | Health | Drug | Pharmaceutical Preparations | Cohen Yuval | MA | DO | CEO | 2 | S.dm | -589 | 10.66 | 0 | -55 | 138 | D | |||||||||||||||
10/27/25 16:22 | 10/24/25 | CRBP | Health | Drug | Pharmaceutical Preparations | Moran Sean F. | MA | O | CFO | 2 | M.d | 276 | 10.64 | 0 | 26 | 55 | 73 | D | ||||||||||||||
10/27/25 16:22 | 10/24/25 | CRBP | Health | Drug | Pharmaceutical Preparations | Moran Sean F. | MA | O | CFO | 2 | S.d | -276 | 10.64 | 0 | -26 | 73 | D | |||||||||||||||
10/21/25 16:54 | 10/20/25 | CRBP | Health | Drug | Pharmaceutical Preparations | Altmeyer Anne | MA | D | 2 | M.d | 27 | 12.65 | 0 | 2 | 52 | 6 | D | |||||||||||||||
10/21/25 16:54 | 10/20/25 | CRBP | Health | Drug | Pharmaceutical Preparations | Altmeyer Anne | MA | D | 2 | S.d | -27 | 12.65 | 0 | -2 | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |